Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
memo - Magazine of European Medical Oncology
Published in: memo - Magazine of European Medical Oncology 4/2023

01-12-2023 | Pancreatic Cancer | editorial

ASCO 2023—partnering with patients: the cornerstone of cancer care and research

Author: Assoc. Prof. PD Dr. Gabriel Rinnerthaler

Published in: memo - Magazine of European Medical Oncology | Issue 4/2023

Login to get access

Excerpt

For the 2023 annual meeting of the American Society of Clinical Oncology (ASCO), over 250 abstracts were finally selected for oral presentations, and over 2000 abstracts for poster presentation. To spread this enormous gain of knowledge, new ways of information exchange have become increasingly important. With webcasts and news tickers, presentations at international congresses can be followed in realtime from at home. Furthermore, continuing medical education events and published reviews illuminate the presented data from different perspectives. In this special edition, Austrian experts summarize the important and most clinically relevant data from this year’s ASCO. …
Literature
1.
2.
Winder T, Reimann P. Essential news from ASCO 2023 in primary resectable and advanced or metastatic pancreatic cancer. 2023in;16(3). DOI.
3.
4.
Metadata
Title
ASCO 2023—partnering with patients: the cornerstone of cancer care and research
Author
Assoc. Prof. PD Dr. Gabriel Rinnerthaler
Publication date
01-12-2023
Publisher
Springer Vienna
Published in
memo - Magazine of European Medical Oncology / Issue 4/2023
Print ISSN: 1865-5041
Electronic ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-023-00930-0

Other articles of this Issue 4/2023

memo - Magazine of European Medical Oncology 4/2023 Go to the issue

original report

WNT3 and LEF1 as markers for diagnosis and survival prediction in chronic lymphocytic leukemia patients

short review

ASCO update—hepatocellular carcinoma and cholangiocellular carcinoma

editorial

Prostate cancer special—part 1

short review

ASCO 2023: new treatment options in CNS tumors

short review

Essential news from ASCO 2023 in primary resectable and advanced or metastatic pancreatic cancer

short review

Erythropoiesis-stimulating agents—benefits and harms in the treatment of anemia in cancer patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits